- Home
- PFL vs MLAB Comparison
PFL vs MLAB Comparison
Compare PFL & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFL | MLAB |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.7M | 461.9M |
| IPO Year | 2003 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PFL | MLAB |
|---|---|---|
| Price | $8.04 | $97.72 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $94.00 |
| AVG Volume (30 Days) | ★ 169.9K | 80.1K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 11.53% | 0.66% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $49.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.60 | $59.63 |
| 52 Week High | $8.70 | $128.55 |
Technical Indicators
Market Signals| Indicator | PFL | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 56.43 |
| Support Level | $7.97 | $69.73 |
| Resistance Level | $8.49 | $103.73 |
| Average True Range (ATR) | 0.06 | 4.17 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 36.36 | 49.00 |
Price Performance
Historical ComparisonAbout PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.